Protocol Memory Deficit in Patients With Obstructive Sleep Apnea Syndrome
Recruitment status was Not yet recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The main objective of this study is to evaluate the evolution of memory deficit (verbal episodic memory, procedural memory, working memory, short-term memory) in Sleep Apnea Obstructive Syndrome (SAOS) patients after treatment by Continuous Positive Airway Pressure treatment (CPAP). For thus, we will compare memory tests in two separate groups of SAOS patients with “effective ” versus “ineffective” ( or sham) CPAP, before and 6 weeks after the beginning of the treatment. Thus we will assess the evolution of memory deficit, the effectiveness of the treatment on the evolution of memory deficit before and 6 weeks after the beginning of the treatment by “effective ” versus “ineffective” CPAP.
We feel the results of the tests of memory will show greater memory disorders in patients with SAOS before beginning the treatment rather than six weeks afterwards. Thus we hypothesise that, after the treatment by "effective" CPAP, the patients with SAOS will have greater improvement of their memory disorders than those treated by "sham CPAP".
| Condition |
|---|
|
Memory Deficit |
| Study Type: | Observational |
| Study Design: | Allocation: Random Sample Time Perspective: Longitudinal Time Perspective: Prospective |
| Official Title: | Comparison of the Evolution of Memory Deficit in Patients With Sleep Apnea Obstructive Syndrome (SAOS) Before and After "Effective" Versus Sham Treatment by Positive Pression Continues (PPC) |
| Estimated Enrollment: | 40 |
| Study Start Date: | April 2007 |
| Estimated Study Completion Date: | January 2008 |
We want to assess the evolution, before and 6 weeks after the beginning of the treatment, of the significant differences of the performances of the various memory tests evaluating several forms of memory (episodic memory, working memory, short-term memory and procedural memory) according to the treatment for patients with SAOS (effective versus sham).
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Major patients,
- agreeing,
- diagnosed suffering from the SAOS,
- regulation by the specialist in a treatment by CPAP,
- patients do not begin the treatment
- affiliated to the social security,
- fluent in French.
Exclusion Criteria:
- Patients presenting severe depressive disorders (HADS score>19),
- intellectual deterioration (MMS< 28),
- a functional failure of the dominant arm upper limb inhibiting realization of graphic tasks,
- an associated oxygen treatment,
- suffering from cancer,
- cerebro-vascular accident,
- pregnant or nursing women,
- adult under supervision or trusteeship,
- patients already included in another research protocol or in period of exclusion,
- antidepressant and anxiolytic treatment.
Contacts and Locations| Contact: Jean-Louis JP PEPIN, ProfessorPhD | 00330476765516 | JPepin@chu-grenoble.fr |
| France | |
| Laboratoire EFCR-Functional Cardio-Respiratory Exploration Laboratory | |
| Grenoble, Isere, France | |
| Principal Investigator: | Jean-Louis JP Pépin, ProfessorPhD | University Hospital, Grenoble |
More Information
Publications:
| ClinicalTrials.gov Identifier: | NCT00464659 History of Changes |
| Other Study ID Numbers: | 0629 |
| Study First Received: | April 20, 2007 |
| Last Updated: | April 20, 2007 |
| Health Authority: | France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis) |
Keywords provided by University Hospital, Grenoble:
|
Sleep apnea obstructive syndrome (SAOS) memory deficit Continuous Positive Airway Pression (CPAP) Sham CPAP |
Additional relevant MeSH terms:
|
Sleep Apnea Syndromes Memory Disorders Sleep Apnea, Obstructive Apnea Respiration Disorders Respiratory Tract Diseases Sleep Disorders, Intrinsic |
Dyssomnias Sleep Disorders Nervous System Diseases Neurobehavioral Manifestations Neurologic Manifestations Signs and Symptoms |
ClinicalTrials.gov processed this record on May 23, 2013